✨ Your Portfolio is fetched and updated from zerodha.
Nano Miscellaneous

Novelix Pharmaceuticals Ltd.

TRIMURTHI

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹96 Cr.
P/E
99.44

Novelix Pharmaceuticals Ltd.

  • Novelix Pharma
  • Fervent Synergies
  • Aviva Inds

FAQs on Novelix Pharmaceuticals Ltd. Shareprice

Novelix Pharma has given better returns compared to its competitors.
Novelix Pharma has grown at ~58.02% over the last 4yrs while peers have grown at a median rate of -0.94%

Yes, Novelix Pharma is expensive.
Latest PE of Novelix Pharma is 94.79, while 3 year average PE is 50.51.
Also latest EV/EBITDA of Novelix Pharma is 73.29 while 3yr average is 27.18.

View FAQ's On Business

Growth Table

  • Novelix Pharmaceuticals Ltd.
  • Fervent Synergies
  • Aviva Inds

Balance Sheet

  • Novelix Pharmaceuticals Ltd.
  • Fervent Synergies
  • Aviva Inds

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Novelix Pharmaceuticals Ltd.
  • Fervent Synergies
  • Aviva Inds

Cash Flow

  • Novelix Pharmaceuticals Ltd.
  • Fervent Synergies
  • Aviva Inds

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Novelix Pharmaceuticals Ltd.
  • Fervent Synergies
  • Aviva Inds

Quarterly Results

  • Novelix Pharmaceuticals Ltd.
  • Fervent Synergies
  • Aviva Inds

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Novelix Pharmaceuticals Ltd. Financials

Balance sheet of Novelix Pharma is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Novelix Pharma is decreasing.
Latest net debt of Novelix Pharma is -₹1.35 Crs as of Mar-25.
This is less than Mar-24 when it was -₹0.22 Crs.

Yes, profit is increasing.
The profit of Novelix Pharma is ₹0.97 Crs for TTM, ₹0.08 Crs for Mar 2025 and ₹0.01 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Novelix Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech